None listed
Conditions
Interventions
None listed
Sponsors
Boehringer Ingelheim India Private Limited
CARE Foundation
Eligibility
Inclusion criteria
Inclusion criteria: 1.Men and women aged eighteen years and above 2.Willing to participate in the study by signing the informed consent form
Exclusion criteria
Exclusion criteria: 1.Individuals not willing to participate in the study. 2.Individuals who are not resident of the selected villages. 3.Individuals who havenâ??t followed instructions for blood glucose testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not applicable. Presence of Atrial Fibrillation on ECG is considered as a case for this prevalence study.Timepoint: The study would end approximately in Febrauary 2019 | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactDrCalambur Narasimhan
CARE hospital
Outcome results
None listed